TherapeuticsMD, Inc. (TXMD)
NasdaqGS - NasdaqGS Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 2.0300 |
| Open | 2.0100 |
| Bid | 1.7200 x 100 |
| Ask | 2.3200 x 100 |
| Day's range | 2.0000 - 2.0300 |
| 52-week range | 1.8400 - 4.7200 |
| Volume | |
| Avg. volume | 22,993 |
| Market cap | 23.411M |
| Beta (5Y monthly) | 1.07 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
TherapeuticsMD Announces First Quarter 2024 Financial Results
BOCA RATON, Fla., May 10, 2024--TherapeuticsMD, Inc. ("TherapeuticsMD" or the "Company") (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the first quarter ended March 31, 2024.
- Business Wire
TherapeuticsMD Announces Full Year 2023 Financial Results
BOCA RATON, Fla., March 29, 2024--TherapeuticsMD, Inc. ("TherapeuticsMD" or the "Company") (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the full year ended December 31, 2023.
- Business Wire
TherapeuticsMD Announces Third Quarter 2023 Financial Results
BOCA RATON, Fla., November 14, 2023--TherapeuticsMD, Inc. ("TherapeuticsMD" or the "Company") (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the third quarter ended September 30, 2023.
© 2024 Yahoo. All rights reserved.